The Problems and Pitfalls of NSAID Therapy in the Elderly (Part I)

[1]  R. Dybkaer,et al.  Relative reference values for clinical chemical and haematological quantities in 'healthy' elderly people. , 2009, Acta medica Scandinavica.

[2]  A. Fro̸land,et al.  Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors. , 2009, Acta medica Scandinavica.

[3]  J. Avorn,et al.  Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. , 1990, JAMA.

[4]  C. Hawkey.  Non-steroidal anti-inflammatory drugs and peptic ulcers. , 1990, BMJ.

[5]  W. Buchanan.  Implications of NSAID therapy in elderly patients. , 1990, The Journal of rheumatology. Supplement.

[6]  R. Milanino,et al.  Nongastrointestinal adverse reactions to NSAID. , 1990, The Journal of rheumatology. Supplement.

[7]  J. Fries,et al.  Identification of patients at risk for gastropathy associated with NSAID use. , 1990, The Journal of rheumatology. Supplement.

[8]  R. Stewart,et al.  Medication compliance in the elderly. , 1989, The Medical clinics of North America.

[9]  W. Waters,et al.  The benefits of prescription information leaflets (1). , 1989, British journal of clinical pharmacology.

[10]  S. Abramson,et al.  The mechanisms of action of nonsteroidal antiinflammatory drugs. , 1989, Arthritis and rheumatism.

[11]  B. Bloom,et al.  Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. , 1989, Archives of internal medicine.

[12]  D. McDevitt,et al.  Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. , 1989, The Quarterly journal of medicine.

[13]  B. Bannwarth,et al.  Hepatitis induced by non-steroidal anti-inflammatory drugs. , 1989, Annals of the rheumatic diseases.

[14]  Sack Ke.  Update on NSAIDS in the elderly. , 1989 .

[15]  S. Miller,et al.  Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. , 1989, Archives of internal medicine.

[16]  Bridges Cr,et al.  Antirheumatic agents: CNS toxicity and its avoidance. , 1989 .

[17]  M. Langman,et al.  Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. , 1989, Gastroenterology.

[18]  D A Bloch,et al.  Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. , 1989, Gastroenterology.

[19]  W. Watson,et al.  Aging and Nonsteroidal Antiinflammatory Drug-Induced Renal Dysfunction , 1989, DICP : the annals of pharmacotherapy.

[20]  S. Roth,et al.  PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL , 1988, The Lancet.

[21]  R. Warne,et al.  A Manual of Geriatric Care , 1988 .

[22]  M. Langman,et al.  Aspirin and bleeding peptic ulcers in the elderly. , 1988, BMJ.

[23]  G. Tildesley,et al.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. , 1988, BMJ.

[24]  F. P. Ryan,et al.  Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. , 1988, BMJ.

[25]  Verbeeck Rk.  Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs. , 1988 .

[26]  W. Schaffner,et al.  Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.

[27]  P. Collet,et al.  Changing the class of NSAID in cases of hepatotoxicity. , 1988, Annals of the rheumatic diseases.

[28]  D. Mazanec.  Nonsteroidal anti-inflammatory drug therapy. Clinical use in a high-risk group--the elderly. , 1988, Cleveland Clinic journal of medicine.

[29]  Champion Gd.  Therapeutic usage of the non-steroidal anti-inflammatory drugs. , 1988 .

[30]  D. Henry.  Side-effects of non-steroidal anti-inflammatory drugs. , 1988, Bailliere's clinical rheumatology.

[31]  L. Wing,et al.  Interactions of non-steroidal anti-inflammatory drugs. , 1988, Bailliere's clinical rheumatology.

[32]  R. Day,et al.  Pharmacokinetics of non-steroidal anti-inflammatory drugs. , 1988, Bailliere's clinical rheumatology.

[33]  D. Furst.  The basis for variability of response to anti-rheumatic drugs. , 1988, Bailliere's clinical rheumatology.

[34]  Roth Sh.  NSAID and gastropathy: a rheumatologist's review. , 1988 .

[35]  D. Larrey,et al.  Hépatites aux anti-inflammatoires non stéroïdiens. Bilan coopératif des centres régionaux de pharmacovigilance pour l'année 1985. , 1988 .

[36]  T. Gibson.  Nonsteroidal anti-inflammatory drugs--another look. , 1988, British journal of rheumatology.

[37]  A. Doube,et al.  Nonsteroidal anti-inflammatory drug-induced dyspepsia--is Campylobacter pyloridis implicated? , 1988, British journal of rheumatology.

[38]  J. Fries.  Postmarketing drug surveillance: are our priorities right? , 1988, The Journal of rheumatology.

[39]  B. Bloom.  Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. , 1988, The American journal of medicine.

[40]  R. Moore,et al.  Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance. , 1988, The American journal of medicine.

[41]  M. Langman.  Ulcer complications and nonsteroidal anti-inflammatory drugs. , 1988, The American journal of medicine.

[42]  U Bergman,et al.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. , 1988, Journal of clinical epidemiology.

[43]  S. Roth,et al.  Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. , 1987, Archives of internal medicine.

[44]  D. Henry,et al.  Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. , 1987, British medical journal.

[45]  W. Wu,et al.  Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. , 1987, The American journal of medicine.

[46]  A. Walker,et al.  Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. , 1987, Archives of internal medicine.

[47]  H. Jick,et al.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER , 1987, The Lancet.

[48]  A. H. Swain,et al.  Cross hepatotoxicity between non-steroidal anti-inflammatory drugs. , 1987, British medical journal.

[49]  D. Cocchetto,et al.  Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory Drugs , 1987, Clinical pharmacokinetics.

[50]  R. Day,et al.  Variations in response to non-steroidal anti-inflammatory drugs. , 1987, British journal of clinical pharmacology.

[51]  W. Wu,et al.  Antiinflammatory drugs and gastric mucosal damage. , 1987, Seminars in arthritis and rheumatism.

[52]  A. Blower,et al.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. , 1987, Gut.

[53]  R. Cockel.  NSAIDs--should every prescription carry a government health warning? , 1987, Gut.

[54]  P. Davis.  Therapeutic options in the selection of nonsteroidal, antiinflammatory drugs in the treatment of osteoarthritis: a review. , 1987, The Journal of rheumatology.

[55]  C. Patrono,et al.  Effects of sulindac on renal and extrarenal eicosanoid synthesis , 1987, Clinical pharmacology and therapeutics.

[56]  H. Wynne,et al.  The Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the Elderly , 1987, Clinical pharmacokinetics.

[57]  G. Faich,et al.  Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. , 1987, British medical journal.

[58]  Y. Pirson,et al.  Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  A. Levi,et al.  Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. , 1986, Gut.

[60]  J. Mcnicholl,et al.  Fatal hepatitis associated with diclofenac. , 1986, Gut.

[61]  R. Day,et al.  Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. , 1986, Australian and New Zealand journal of medicine.

[62]  K. Farrell,et al.  The effect of aspirin on valproic acid metabolism , 1986, Clinical pharmacology and therapeutics.

[63]  P. Gøtzsche,et al.  Rational choice of dose: insufficient background knowledge? , 1986, Rational drug therapy.

[64]  S. Roth.  Nonsteroidal anti-inflammatory drug gastropathy. We started it--can we stop it? , 1986, Archives of internal medicine.

[65]  Mcqueen Eg,et al.  Non-steroidal anti-inflammatory drugs and platelet function. , 1986, The New Zealand medical journal.

[66]  J. Spence,et al.  EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS , 1986, The Lancet.

[67]  A. Kelman,et al.  Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis. , 1986, British journal of clinical pharmacology.

[68]  Paulus He,et al.  Non-steroidal and analgesic therapy in the elderly. , 1986 .

[69]  D. Furst,et al.  Implications of drug therapy in the elderly. , 1986, Clinics in rheumatic diseases.

[70]  J. Dequeker,et al.  Immunomodulatory effects of treatment with naproxen in patients with rheumatic disease. , 1986, Arthritis and rheumatism.

[71]  M. Langman,et al.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER , 1986, The Lancet.

[72]  R. Logan,et al.  RISING FREQUENCY OF ULCER PERFORATION IN ELDERLY PEOPLE IN THE UNITED KINGDOM , 1986, The Lancet.

[73]  M. Namer,et al.  CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN , 1986, The Lancet.

[74]  J. Griffin.  Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries. , 1986, British journal of clinical pharmacology.

[75]  T. Sullivan,et al.  Inability of ibuprofen to alter single dose phenytoin disposition. , 1986, British journal of clinical pharmacology.

[76]  G. Dibona.  Prostaglandins and nonsteroidal anti-inflammatory drugs. Effects on renal hemodynamics. , 1986, The American journal of medicine.

[77]  Woodhouse Kw.  Drugs and the ageing gut, liver and pancreas. , 1985 .

[78]  A. Renwick,et al.  Sulindac metabolism: The importance of an intact colon , 1985, Clinical pharmacology and therapeutics.

[79]  Judith K Jones.  Adverse Drug Reaction Considerations in Geriatric Drug Research , 1985 .

[80]  P. Murdoch,et al.  Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem. , 1985, British medical journal.

[81]  R. Vandongen,et al.  Differential effects of sulindac and indomethacin on blood pressure in treated essential hypertensive subjects. , 1985, Clinical science.

[82]  S. Bazire,et al.  An Interaction between Lithium Carbonate and Piroxicam Presenting as Lithium Toxicity , 1985, British Journal of Psychiatry.

[83]  P. Mitenko,et al.  Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac , 1985, Clinical pharmacology and therapeutics.

[84]  J. Minta,et al.  Some nonsteroidal antiinflammatory drugs inhibit the generation of superoxide anions by activated polymorphs by blocking ligand-receptor interactions. , 1985, The Journal of rheumatology.

[85]  A. Zimran,et al.  Incidence of hyperkalaemia induced by indomethacin in a hospital population. , 1985, British medical journal.

[86]  R. Ling,et al.  ACETABULAR BONE DESTRUCTION RELATED TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS , 1985, The Lancet.

[87]  P. Netter,et al.  Salicylate kinetics in old age , 1985, Clinical pharmacology and therapeutics.

[88]  D. Kennedy,et al.  Utilization of nonsteroidal antiinflammatory drugs. , 1985, Arthritis and rheumatism.

[89]  S. Shankel,et al.  Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. , 1985, The American journal of medicine.

[90]  D. Graham,et al.  Effects of aspirin and an aspirin-acetaminophen combination on the gastric mucosa in normal subjects. A double-blind endoscopic study. , 1985, Gastroenterology.

[91]  J. Davies,et al.  The Effect of Sulindac on Lithium Therapy , 1985, Drug intelligence & clinical pharmacy.

[92]  R. Day,et al.  Stereoselective disposition of ibuprofen enantiomers in infants. , 1985 .

[93]  J. Pain,et al.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. , 1985, Gut.

[94]  G. Koren,et al.  Possible indomethacin-aminoglycoside interaction in preterm infants. , 1985, The Journal of pediatrics.

[95]  E. Nm,et al.  Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: a possible adverse effect due to concomitant indomethacin administration. , 1985 .

[96]  J. Najarian,et al.  Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. , 1985, Archives of internal medicine.

[97]  O'brien Wm,et al.  Rare adverse reactions to non-steroidal anti-inflammatory drugs , 1985 .

[98]  J. Blackshear,et al.  Renal complications of nonsteroidal antiinflammatory drugs: identification and monitoring of those at risk. , 1985, Seminars in arthritis and rheumatism.

[99]  J. Bernuau,et al.  Hépatite fulminante chez une femme prenant de la glafénine et du diclofénac. , 1985 .

[100]  D. Greenblatt,et al.  Absorption and disposition of ibuprofen in the elderly. , 1984, Arthritis and rheumatism.

[101]  R. Day,et al.  Aspects of the clinical pharmacology of non-steroidal anti-inflammatory drugs. , 1984, Clinics in rheumatic diseases.

[102]  R. Williams,et al.  Naproxen pharmacokinetics in the elderly. , 1984, British journal of clinical pharmacology.

[103]  F. Lanza.  Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. , 1984, The American journal of medicine.

[104]  M. Dunn,et al.  Effects of sulindac and indomethacin on renal prostaglandin synthesis , 1984, Clinical pharmacology and therapeutics.

[105]  R. Verbeeck,et al.  Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation. , 1984, British journal of clinical pharmacology.

[106]  D. Jahnigen,et al.  Child‐resistant Packaging and the Geriatric Patient , 1984, Journal of the American Geriatrics Society.

[107]  S. Garella,et al.  Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti‐Inflammatory Agents , 1984, Medicine.

[108]  I. Litt,et al.  Compliance with therapeutic regimens. , 1984, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[109]  P. Ho,et al.  Drug therapy in the elderly. , 1984, Australian and New Zealand journal of medicine.

[110]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[111]  C. Patrono,et al.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. , 1984, The New England journal of medicine.

[112]  D. Waller.  Hypoglycaemia due to azapropazone-tolbutamide interaction. , 1984, British journal of rheumatology.

[113]  D. L. Schmucker.  Drug Disposition in the Elderly: A Review of the Critical Factors , 1984, Journal of the American Geriatrics Society.

[114]  P. Meffin,et al.  Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. , 1983, The Journal of pharmacology and experimental therapeutics.

[115]  A. Woolf,et al.  Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients. , 1983, British journal of clinical pharmacology.

[116]  James Of.  Gastrointestinal and liver function of old age. , 1983 .

[117]  G. Nuki.  Non-steroidal analgesic and anti-inflammatory agents. , 1983, British medical journal.

[118]  O. Varoquaux,et al.  Pharmacokinetics of ketoprofen in the elderly. , 1983, British journal of clinical pharmacology.

[119]  R. Verbeeck,et al.  Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs , 1983, Clinical pharmacokinetics.

[120]  M. Penno,et al.  Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation. , 1983, The Journal of clinical investigation.

[121]  J. G. Carver,et al.  Pharmacokinetic investigation of the interaction of azapropazone with phenytoin. , 1983, British journal of clinical pharmacology.

[122]  J. Blackshear,et al.  Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. , 1983, Archives of internal medicine.

[123]  P. Meffin,et al.  Diflunisal disposition and hypouricemic response in osteoarthritis , 1983, Clinical pharmacology and therapeutics.

[124]  S. Pitlik,et al.  Indomethacin- and Moduretic--induced hyperkalemia. , 1983, Israel journal of medical sciences.

[125]  J. Fries,et al.  From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. , 1983, The American journal of medicine.

[126]  J. D. Robinson,et al.  The Effect of Ibuprofen on Serum Digoxin Concentrations , 1983, Drug intelligence & clinical pharmacy.

[127]  J. Frölich,et al.  Indomethacin but not aspirin increases plasma lithium ion levels. , 1983, Archives of general psychiatry.

[128]  M. Dobrinska,et al.  Enterohepatic circulation of sulindac and metabolites , 1983, Clinical pharmacology and therapeutics.

[129]  Fumio Inoue,et al.  Folate supplements and phenytoin‐sa]licylate interaction , 1983, Neurology.

[130]  S. Textor,et al.  Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. , 1982, The American journal of medicine.

[131]  D. L. Scott,et al.  Variations in responses to non-steroidal anti-inflammatory drugs. , 1982, British journal of clinical pharmacology.

[132]  J. Whitworth,et al.  Non-steroidal anti-inflammatory drugs and blood pressure. , 1982, Australian and New Zealand journal of medicine.

[133]  F. Caird,et al.  Drug Treatment of the Elderly Patient , 1982 .

[134]  B. Swanson,et al.  Sulindac disposition when given once and twice daily , 1982, Clinical pharmacology and therapeutics.

[135]  I. Samloff,et al.  Age- and sex-related behaviour of gastric acid secretion at the population level. , 1982, Scandinavian journal of gastroenterology.

[136]  J. C. O'Laughlin,et al.  Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa. , 1982, Gut.

[137]  J. Goodwin,et al.  Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. , 1982, Arthritis and rheumatism.

[138]  I. Fellows,et al.  Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. , 1982, British medical journal.

[139]  C. J. Jones,et al.  Pharmacokinetics of azapropazone in the elderly. , 1982, British journal of clinical pharmacology.

[140]  Roger L. Williams,et al.  Effects of probenecid on ketoprofen kinetics , 1982, Clinical pharmacology and therapeutics.

[141]  R. Day,et al.  Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis , 1982, Clinical pharmacology and therapeutics.

[142]  D. Greenblatt,et al.  Drug disposition in old age. , 1982, The New England journal of medicine.

[143]  R. Willkens,et al.  Clinical comparison of ibuprofen, fenoprofen calcium, naproxen and tolmetin sodium in rheumatoid arthritis. , 1982, The Journal of rheumatology.

[144]  W. Godolphin,et al.  Interaction between valproic acid and aspirin in epileptic children: Serum protein binding and metabolic effects , 1982, Clinical pharmacology and therapeutics.

[145]  N. Sreeharan,et al.  Assessment of the Interaction of Warfarin with Aspirin and Dipyridamole , 1982, Thrombosis and Haemostasis.

[146]  J. Fries,et al.  Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis. , 1981, JAMA.

[147]  D. Greenblatt,et al.  Clobazam kinetics in the elderly. , 1981, British journal of clinical pharmacology.

[148]  R. Mactier,et al.  Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide-induced diuresis in cardiac failure. , 1981, British medical journal.

[149]  J. Frölich,et al.  Effects of diclofenac on lithium kinetics , 1981, Clinical pharmacology and therapeutics.

[150]  J. Chalmers,et al.  THE EFFECTS OF INDOMETHACIN IN TREATED HYPERTENSIVE PATIENTS , 1981, Clinical and experimental pharmacology & physiology.

[151]  P. Deschepper,et al.  Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states , 1981, Clinical pharmacology and therapeutics.

[152]  H. Creasey,et al.  Gastric Emptying Rate in the Elderly: Implications for Drug Therapy , 1981, Journal of the American Geriatrics Society.

[153]  K. Ishak,et al.  Phenylbutazone liver injury: A clinical‐pathologic survey of 23 cases and review of the literature , 1981, Hepatology.

[154]  G. Tucker,et al.  Clinical pharmacology: drugs and the elderly. , 1981, British medical journal.

[155]  M. Rawlins,et al.  The effect of age on the pharmacokinetics of diazepam. , 1980, Clinical science.

[156]  A. Breckenridge,et al.  Interaction between diflunisal and warfarin , 1980, Clinical pharmacology and therapeutics.

[157]  Robinson Pg.  Ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions. , 1980 .

[158]  J. Hoftiezer,et al.  COMPARISON OF THE EFFECTS OF REGULAR AND ENTERIC-COATED ASPIRIN ON GASTRODUODENAL MUCOSA OF MAN , 1980, The Lancet.

[159]  C. Dollery,et al.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. , 1980, British medical journal.

[160]  T. Blaschke,et al.  Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin. , 1980, British journal of clinical pharmacology.

[161]  Simon Ls,et al.  Nonsteroidal antiinflammatory drugs (second of two parts). , 1980, The New England journal of medicine.

[162]  P. Hansten,et al.  Effect of Antacid and Ascorbic Acid on Serum Salicylate Concentration , 1980, Journal of clinical pharmacology.

[163]  T. L. Thornton.  Delirium associated with sulindac. , 1980, JAMA.

[164]  J. F. Gardocki,et al.  Evaluation of the Analgesic Properties of Zomepirac , 1980, Journal of clinical pharmacology.

[165]  R. Oldham,et al.  Ketotifen in adult asthma. , 1980, British medical journal.

[166]  A. Breckenridge,et al.  The effect of diflunisal on the steady state pharmacodynamics and pharmacokinetics of warfarin [proceedings]. , 1980, British journal of clinical pharmacology.

[167]  W. Trager,et al.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man. , 1980, The Journal of clinical investigation.

[168]  D. G. Fraser,et al.  Displacement of phenytoin from plasma binding sites by salicylate , 1980, Clinical pharmacology and therapeutics.

[169]  G. E. Johnson,et al.  Drug prescribing for the elderly in Saskatchewan during 1976. , 1979, Canadian Medical Association journal.

[170]  K. Ivey,et al.  Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. , 1979, Annals of internal medicine.

[171]  D. Furst,et al.  Salicylate clearance, the resultant of protein binding and metabolism , 1979, Clinical pharmacology and therapeutics.

[172]  E. Valovirta,et al.  Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia. , 1979, Anesthesiology.

[173]  F. Stitt,et al.  Increasing dose of naproxen in rheumatoid arthritis: use with and without corticosteroids. , 1979, The Journal of rheumatology.

[174]  K. O’malley,et al.  Digoxin in the elderly: Pharmacokinetic consequences of old age , 1979, Clinical pharmacology and therapeutics.

[175]  R. Verbesselt,et al.  Effect of aluminum hydroxide on diflunisal absorption. , 1979, British journal of clinical pharmacology.

[176]  J. Oates,et al.  Indomethacin increases plasma lithium. , 1979, British medical journal.

[177]  W. V. D. van den Heuvel,et al.  Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders , 1979, Annals of the rheumatic diseases.

[178]  Anderson Rj.  Severe reaction associated with sulindac administration. , 1979 .

[179]  D. Brater,et al.  Effect of indomethacin on salt and water homeostasis , 1979, Clinical pharmacology and therapeutics.

[180]  D. Anderson.  Book ReviewAnterior Segment Fluorescein Angiography. , 1979 .

[181]  D. Greenblatt.  Reduced Serum Albumin Concentration in the Elderly: A Report from the Boston Collaborative Drug Surveillance Program , 1979, Journal of the American Geriatrics Society.

[182]  E. Mroszczak,et al.  Naproxen‐probenecid interaction , 1978, Clinical pharmacology and therapeutics.

[183]  G. Udkow.  Pediatric clinical pharmacology. A practical review. , 1978, American journal of diseases of children.

[184]  K. Rainsford.  The effects of aspirin and other non-steroid anti-inflammatory/analgesic drugs on gastro-intestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions. , 1978, Biochemical pharmacology.

[185]  K. Brune,et al.  Non-steroid anti-inflammatory drugs: influence of extra-cellular pH on biodistribution and pharmacological effects. , 1978, Biochemical pharmacology.

[186]  P. Majerus,et al.  Inhibition of platelet prostaglandin synthetase by oral aspirin. , 1978, The Journal of clinical investigation.

[187]  M. Prata,et al.  MODIFICATION OF ANTIHYPERTENSIVE EFFECT OF &bgr;-ADRENOCEPTOR-BLOCKING AGENTS BY INHIBITION OF ENDOGENOUS PROSTAGLANDIN SYNTHESIS , 1977, The Lancet.

[188]  S. Pond,et al.  Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazole , 1977, Clinical pharmacology and therapeutics.

[189]  M. Levy,et al.  Drug utilization and adverse drug reactions in medical patients: comparison of two periods, 1969--72 and 1973--76. , 1977, Israel journal of medical sciences.

[190]  M. Carney.  Paranoid psychosis with indomethacin. , 1977, British medical journal.

[191]  G. Graham,et al.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis , 1977, Clinical pharmacology and therapeutics.

[192]  H. Capell,et al.  Anti-inflammatory analgesic drug responders and non-responders: a clinico-pharmacological study of flurbiprofen. , 1977, British journal of clinical pharmacology.

[193]  W. Inman.  Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. , 1977, British medical journal.

[194]  H. Leach,et al.  Potentiation of warfarin by azapropazone. , 1977, British medical journal.

[195]  A. H. Norris,et al.  Aging and ethanol metabolism , 1977, Clinical pharmacology and therapeutics.

[196]  V. Cirillo,et al.  Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans. , 1977, British journal of clinical pharmacology.

[197]  M. Pathy,et al.  The effects of discontinuing long-term diuretic therapy in the elderly. , 1977, Age and ageing.

[198]  R. Macgregor.  The effect of anti-inflammatory agents and inflammation on granulocyte adherence. Evidence for regulation by plasma factors. , 1976, The American journal of medicine.

[199]  G. A. Hunter,et al.  DRUG INTERACTION IN PSORIASIS * , 1976, The Australasian journal of dermatology.

[200]  R. Willkens,et al.  Combination therapy with naproxen and aspirin in rheumatoid arthritis. , 1976, Arthritis and rheumatism.

[201]  E. Huskisson,et al.  Four new anti-inflammatory drugs: responses and variations. , 1976, British medical journal.

[202]  B. Whiting,et al.  Factors affecting drug binding in plasma of elderly patients. , 1976, British journal of clinical pharmacology.

[203]  R. Law,et al.  Medicines and elderly people: a general practice survey. , 1976, British medical journal.

[204]  W. Taylor,et al.  Who responds to sugar pills? , 1976, Mayo Clinic proceedings.

[205]  G. Reichard,et al.  Plasma protein binding of drugs as a function of age in adult human subjects. , 1975, Journal of pharmaceutical sciences.

[206]  W. Buchanan,et al.  Indomethacin--aspirin interaction: a clinical appraisal. , 1975, British medical journal.

[207]  J. Vane,et al.  Possible Contributions of Endogenous Prostaglandins to the Control of Blood Pressure , 1975, Circulation research.

[208]  R. Lewis,et al.  Warfarin-phenylbutazone interaction in man: a long term multiple dose study. , 1975, Research communications in chemical pathology and pharmacology.

[209]  U. Klotz,et al.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man. , 1975, The Journal of clinical investigation.

[210]  M. Becker,et al.  Sociobehavioral Determinants of Compliance with Health and Medical Care Recommendations , 1975, Medical care.

[211]  H. Sevelius,et al.  Letter: Transport of organic acids across cell membrane. , 1974 .

[212]  P. Brooks,et al.  The clinical significance of indomethacin-probenecid interaction. , 1974, British journal of clinical pharmacology.

[213]  A. Breckenridge,et al.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. , 1974, The Journal of clinical investigation.

[214]  M. Gibaldi,et al.  DRUG ELIMINATION AND RENAL FUNCTION , 1974 .

[215]  John A. Mills.  Nonsteroidal Anti-Inflammatory Drugs , 1974 .

[216]  G S Kellaway,et al.  Intensive monitoring for adverse drug effects in patients discharged from acute medical wards. , 1973, The New Zealand medical journal.

[217]  J. Vane,et al.  Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. , 1973, The Journal of pharmacology and experimental therapeutics.

[218]  L. P. Novâk,et al.  Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. , 1972, Journal of gerontology.

[219]  R. Stewart,et al.  A review of medication errors and compliance in ambulant patients , 1972, Clinical pharmacology and therapeutics.

[220]  G. Levy,et al.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.

[221]  J. Mazzullo.  The nonpharmacologic basis of therapeutics , 1972, Clinical pharmacology and therapeutics.

[222]  M. Rowland,et al.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution. , 1972, Journal of pharmaceutical sciences.

[223]  K. Malik,et al.  Differential effect of noradrenaline and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin E-like substance. , 1972, Clinical science.

[224]  J. Crooks,et al.  Effect of Age and Sex on Human Drug Metabolism , 1971, British medical journal.

[225]  G. Levy,et al.  Urine pH and salicylate therapy. , 1971, JAMA.

[226]  G. Forbes,et al.  Adult lean body mass declines with age: some longitudinal observations. , 1970, Metabolism: clinical and experimental.

[227]  M. Nevins,et al.  Phenylbutazone and pulmonary oedema. , 1969, Lancet.

[228]  E. Henderson,et al.  The effect of organic acids on renal clearance of methotrexate in man , 1969, Clinical pharmacology and therapeutics.

[229]  M. C. Geokas,et al.  The aging gastrointestinal tract. , 1969, American journal of surgery.

[230]  B. Korsch,et al.  Gaps in doctor-patient communication. Patients' response to medical advice. , 1969, The New England journal of medicine.

[231]  N Hurwitz,et al.  Predisposing Factors in Adverse Reactions to Drugs , 1969, British medical journal.

[232]  I. Bouchier,et al.  Determination of faecal blood-loss after combined alcohol and sodium-acetylsalicylate intake. , 1969, Lancet.

[233]  K. Goulston,et al.  Alcohol, Aspirin, and Gastrointestinal Bleeding , 1968, British medical journal.

[234]  A. Bender.  EFFECT OF AGE ON INTESTINAL ABSORPTION: IMPLICATIONS FOR DRUG ABSORPTION IN THE ELDERLY , 1968, Journal of the American Geriatrics Society.

[235]  L. A. Healey,et al.  The renal excretion of indomethacin and its inhibition by probenecid , 1968, Clinical pharmacology and therapeutics.

[236]  G. Nordby,et al.  Measurement of synovial fluid pH in normal and arthritic knees. , 1966, Arthritis and rheumatism.

[237]  J. Klinenberg,et al.  Effect of corticosteroids on blood salicylate concentration. , 1965, JAMA.

[238]  A. Bender.  THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN , 1965 .

[239]  L. Cluff,et al.  STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE. , 1964, JAMA.

[240]  M. Fisher,et al.  OLD PEOPLE AT HOME. THEIR UNREPORTED NEEDS. , 1964, Lancet.

[241]  L. A. Wilson,et al.  Multiple disorders in the elderly. A clinical and statistical study. , 1962, Lancet.

[242]  V. Korenchevsky.  Physiological and Pathological Ageing , 1960 .

[243]  J. Stowers,et al.  A CLINICAL AND PHARMACOLOGICAL COMPARISON OF CHLORPROPAMIDE AND OTHER SULFONYLUREAS , 1959, Annals of the New York Academy of Sciences.

[244]  B. Billing,et al.  Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow. , 1950, The Journal of laboratory and clinical medicine.

[245]  J. Berkson,et al.  THE NORMAL RANGE OF GASTRIC ACIDITY FROM YOUTH TO OLD AGE: AN ANALYSIS OF 3,746 RECORDS , 1932 .

[246]  G. Volans,et al.  Recent advances in clinical pharmacology , 1989 .

[247]  L. Altomonte,et al.  Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs. , 1989, Panminerva medica.

[248]  A. Favero.  Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout , 1989 .

[249]  K. Williams,et al.  The contribution of enantiomers to variability in response to anti-inflammatory drugs. , 1988, Agents and actions. Supplements.

[250]  R. Meyboom,et al.  Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly. , 1988, Age and ageing.

[251]  M. Lequesne.  Alternative therapies for high-risk elderly rheumatic patients. , 1988, Gerontology.

[252]  S. Doherty,et al.  Non-steroidal anti-inflammatories: outpatient audit of patient preferences and side-effects in different diseases , 1987 .

[253]  B. Wiholm,et al.  Trends and patterns in adverse drug reactions to non-steroidal anti-inflammatory drugs reported in Sweden , 1987 .

[254]  J. Roujeau,et al.  Clinical aspects of skin reactions to NSAIDs. , 1987, Scandinavian journal of rheumatology. Supplement.

[255]  R. Day,et al.  Clinical pharmacology of non-steroidal anti-inflammatory drugs. , 1987, Pharmacology & therapeutics.

[256]  G. Velo,et al.  Side-Effects of Anti-Inflammatory Drugs , 1987, Inflammation and Drug Therapy Series.

[257]  B. Strom,et al.  The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. , 1987, Archives of internal medicine.

[258]  D. Furst,et al.  Nonsteroidal anti-inflammatory drugs : mechanisms and clinical uses , 1987 .

[259]  D. Ebel,et al.  Effect of Clinoril (sulindac, MSD), piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension. , 1986, Scandinavian journal of rheumatology. Supplement.

[260]  Prescott Lf.  Liver damage with non-narcotic analgesics. , 1986 .

[261]  Langman Mj.  Anti-inflammatory drug intake and the risk of ulcer complications. , 1986 .

[262]  S. Dahlén,et al.  Leukotrienes and other eicosanoids as mediators of airway obstruction. , 1986, Respiration; international review of thoracic diseases.

[263]  Hollister Le.  Pharmacotherapeutic considerations in anxiety disorders. , 1986, The Journal of clinical psychiatry.

[264]  W. Campbell,et al.  Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. , 1985, Kidney international.

[265]  L. Powell,et al.  Alterations in the liver with ageing. , 1985, Clinics in gastroenterology.

[266]  McGill Pe.  NSAID-plasma concentration monitoring--optimizing treatment of R.A. , 1985 .

[267]  B. H. Ch. Stricker,et al.  Drug-induced Hepatic Injury , 1985 .

[268]  S. Ashley,et al.  Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. , 1985, American journal of surgery.

[269]  K. Rainsford,et al.  Newer anti-inflammatory drugs , 1985 .

[270]  N. Bellamy.  Variance in NSAID studies: contribution of patient variance. , 1985, Agents and actions. Supplements.

[271]  K. Williams,et al.  Stereoselective disposition--basis for variability in response to NSAID's. , 1985, Agents and actions. Supplements.

[272]  Meffin Pj.  The effect of renal dysfunction on the disposition of non-steroidal anti-inflammatory drugs forming acyl-glucuronides. , 1985 .

[273]  M. M. Cohen,et al.  Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study. , 1985, Gastroenterology.

[274]  J. Chalmers,et al.  Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. , 1984, Clinical and experimental hypertension. Part A, Theory and practice.

[275]  B. O'Brien,et al.  Patterns of European Diagnoses and Prescribing , 1984 .

[276]  A. Domínguez-Gil,et al.  Interaction of naproxen with cholestyramine. , 1984, Biopharmaceutics & drug disposition.

[277]  T. Crook.  Geriatric psychopharmacology: progress in the past decade and directions for the next. , 1983, Psychopharmacology bulletin.

[278]  G. Wilkinson.  Drug distribution and renal excretion in the elderly. , 1983, Journal of chronic diseases.

[279]  J. Crooks.  Rational therapeutics in the elderly. , 1983, Journal of chronic diseases.

[280]  W. Buchanan,et al.  NSAID and osteoarthritis--help or hindrance? , 1982, The Journal of rheumatology.

[281]  J. C. O'Laughlin,et al.  Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. , 1981, Scandinavian journal of gastroenterology. Supplement.

[282]  W. Lands.  Actions of anti-inflammatory drugs , 1981 .

[283]  H. Rogers,et al.  Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects. , 1981, European journal of rheumatology and inflammation.

[284]  Y. Imai,et al.  Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension. , 1980, Clinical science.

[285]  R. DeFronzo,et al.  Hyperkalemia and hyporeninemic hypoaldosteronism. , 1980, Kidney international.

[286]  A. Shepherd,et al.  A survey of hospital prescribing for the elderly , 1979 .

[287]  R. Royer,et al.  Pharmacokinetics of salicylates in elderly. , 1979, Gerontology.

[288]  G. Weissmann,et al.  Advances in inflammation research , 1979 .

[289]  R. E. Owen,et al.  Drugs and the Elderly , 1979, Palgrave Macmillan UK.

[290]  M. Kendall,et al.  Pharmacokinetic studies on diclofenac sodium in young and old volunteers. , 1978, Scandinavian journal of rheumatology. Supplement.

[291]  T. Shen.  Prostaglandin Synthetase Inhibitors I , 1977 .

[292]  L. Arisz,et al.  The effect of indomethacin on kidney function and plasma renin activity in man. , 1976, Nephron.

[293]  B. C. Abbott,et al.  A commentary on muscle mechanics. , 1975, Circulation research.

[294]  C. Bentzel,et al.  Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. , 1975, Prostaglandins.

[295]  L. Kupper,et al.  Medication use and misuse: physician-patient discrepancies. , 1975, Journal of chronic diseases.

[296]  Fikry Me,et al.  INTESTINAL ABSORPTION IN THE OLD. , 1965 .

[297]  A. H. Norris,et al.  Age differences in the water content of the body as related to basal oxygen consumption in males. , 1963, Journal of gerontology.